Merck (MRK) Says HPS2-THRIVE Missed Primary Endpoint
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Merck's (MRK) Tredaptive Miss May Benefit Amarin (AMRN) - Analyst
December 20, 2012 2:12 PM ESTAmarin (Nasdaq: AMRN) shares are pressured today, down about 3.8 percent on the session. But, could there be some good news on the horizon for the pharmceutical company?
Jefferies analyst Thomas Wei thinks so. According to Wei, Merck's (NYSE: MRK)... More
